For COVID-19 vaccine updates, please review our information guide and sign up for Connect. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

TitlePhosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.
Publication TypeJournal Article
Year of Publication1999
AuthorsBibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC, Nairn AC, Greengard P
Date Published1999 Dec 9
KeywordsAnimals, CDC2 Protein Kinase, Cyclic AMP-Dependent Protein Kinases, Cyclin-Dependent Kinase 5, Cyclin-Dependent Kinases, Dopamine, Dopamine and cAMP-Regulated Phosphoprotein 32, Enzyme Inhibitors, Mice, Nerve Tissue Proteins, Neurons, Phosphoproteins, Phosphorylation, Recombinant Proteins, Signal Transduction, Threonine

The physiological state of the cell is controlled by signal transduction mechanisms which regulate the balance between protein kinase and protein phosphatase activities. Here we report that a single protein can, depending on which particular amino-acid residue is phosphorylated, function either as a kinase or phosphatase inhibitor. DARPP-32 (dopamine and cyclic AMP-regulated phospho-protein, relative molecular mass 32,000) is converted into an inhibitor of protein phosphatase 1 when it is phosphorylated by protein kinase A (PKA) at threonine 34. We find that DARPP-32 is converted into an inhibitor of PKA when phosphorylated at threonine 75 by cyclin-dependent kinase 5 (Cdk5). Cdk5 phosphorylates DARPP-32 in vitro and in intact brain cells. Phospho-Thr 75 DARPP-32 inhibits PKA in vitro by a competitive mechanism. Decreasing phospho-Thr 75 DARPP-32 in striatal slices, either by a Cdk5-specific inhibitor or by using genetically altered mice, results in increased dopamine-induced phosphorylation of PKA substrates and augmented peak voltage-gated calcium currents. Thus DARPP-32 is a bifunctional signal transduction molecule which, by distinct mechanisms, controls a serine/threonine kinase and a serine/threonine phosphatase.

Alternate JournalNature
PubMed ID10604473
Grant ListP01 DA010044 / DA / NIDA NIH HHS / United States